Alteogen (196170) closed in the 240,000-won range on the regular session on the 8th, extending its decline. As the broader KOSDAQ market showed weakness, Alteogen could not escape the downward trend. The KOSDAQ index finished the day at 892.27, down 6.16 points (-0.69%) from the previous trading day. Notably, this was the last trading day before the Hangeul Day market holiday, and with the index failing to recover the 900 level, attention is growing over the market's direction after the extended holiday.

■ Merger with Alteogen Biologics Underway... Move to Integrate Functions

Alteogen recently launched a restructuring of its business by pursuing a merger with its subsidiary Alteogen Biologics. The two companies laid out a plan to combine their respective functions—research and development and manufacturing, clinical and regulatory affairs, and marketing—into a single organization. The aim is to integrate functions scattered across business stages and efficiently manage the entire process from drug development to market entry. The company also expects the move to reduce organizational operating costs and ease its financial burden.

According to the disclosed merger plan, Alteogen will remain the surviving entity while Alteogen Biologics will be dissolved after the merger. The merger ratio has been set at 0.1679581 Alteogen Biologics shares per one Alteogen common share, with the merger date scheduled for December 29.

■ In-Person Shareholder Meeting on the 15th... Company to Explain Rationale for Merger

A schedule for communicating with shareholders has also been arranged. Alteogen plans to hold an in-person meeting with shareholders on the 15th at Hannam University's Daedeok Valley Campus in Daejeon. At the session, the company intends to explain the background and key details of the merger and address shareholders' questions through a Q&A.

However, attention is focused on how these internal corporate changes will affect the stock price going forward. The progress of the merger process and the tangible results of the business integration will need to be watched. Interest is concentrated on whether Alteogen, which finished trading in the 240,000-won range ahead of the Hangeul Day holiday, can find a catalyst for a rebound in the next session on the 12th.

[※ This article is provided for investment reference purposes only and does not constitute a recommendation to buy or sell any specific stock. The final investment decision and responsibility rest with the investor.]